In the seven months of 2023, Russia more than doubled its imports of pharmaceutical products from Brazil. reported DEA News With reference to the Brazilian Statistics Service.
In monetary terms, purchases increased to $3.8 million from $1.7 million a year earlier. In physical terms, the growth was 93 percent compared to the same period of 2021. The agency states that the indicator has almost reached its historical maximum recorded in 2010.
The bulk of the imports were insulins from the Danish company Novo Nordisk, which localized production in Brazil. We are talking about such drugs as “Fiasp”, “Protafan” and “Actrapid”, which are popular and sought-after drugs in the treatment of diabetes. Certain types of pharmaceuticals, oral and dental hygiene products, and essential oils were also purchased.
According to Nikolai Bespalov, Development Director of the analytical company RNC Pharma, the sharp increase in purchases is linked to the policy of import substitution in an environment of sanctions and logistics restrictions. Imported drugs in Russia mostly have analogues, but some modern insulin preparations are not yet produced in the country.
In early September, Russian pharmacies beginning We produce special medicines for patients.
Previously in the State Duma made Draft law on free drugs for Russians.